focus -WSS

focus

author：knowledge 2025-10-09 06:43:41 - browse：47419

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Some of the ways extreme heat will change life as we know it

focus

WSS

Faced with fears of OxyContin misuse, sales reps touted its safety

Some of the ways extreme heat will change life as we know it

Large hospital system sues Multiplan for low

After John Oliver segment, STAT readers share their opioid

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Target recalls 2.2 million additional candles due to laceration, burn hazards

knowledge

focus

explore

At least 13 dead in Texas as scorching temps continue

Mom launches Girl Scout troop for LGBTQ youth in Texas

ChatGPT in medicine: STAT answers readers' burning questions

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Duchenne breakthrough therapy leaves behind pioneering families

Bispecific antibodies are next new thing in cancer immunotherapy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Kim Kardashian sparks debate on benefits of full

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

GOP presidential candidates start declaring their loyalty

hotspot

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Novo pauses ads for weight loss drug Wegovy amid demand

Some of the ways extreme heat will change life as we know it

Millions may soon lose Medicaid when they don't have to

Novo pauses ads for weight loss drug Wegovy amid demand

hotspot

focus

focus

Wikipedia